GSK To Pay $$2.2 Billion To Settle Majority Of Zantac Cases In United States

( October 10, 2024, 2:05 PM EDT) -- LONDON — GSK PLC announced Oct. 9 that it has reached settlement agreements to end approximately 80,000 Zantac (ranitidine) state court product liability cases pending against the pharmaceutical company in the United States....

Related Sections